Medical treatment of endometriosis: Current evidence and guideline-based recommendations Medikamentöse Therapie der Endometriose: Aktuelle Therapieempfehlungen auf Basis der S2k-Leitlinie

Burghaus S (2026)

Publication Type: Journal article

Publication year: 2026

Journal

Abstract

Drug therapy is a central component of endometriosis treatment and is primarily aimed at controlling pain-related symptoms and suppressing disease activity. The current S2k guideline recommends individualized, symptom-oriented therapy that takes into account the patient’s specific situation, any desire to have children, and the side effect profile. Progestins and oral gonadotropin-releasing hormone (GnRH) antagonists (these after previous surgery) constitute first-line therapy. Although GnRH agonists are effective options for treatment-refractory cases or specific situations, they require careful management of side effects. The choice of therapy should always be made within the context of long-term disease management.

Authors with CRIS profile

Stefanie Burghaus Department of Obstetrics and Gynaecology

How to cite

APA:

Burghaus, S. (2026). Medical treatment of endometriosis: Current evidence and guideline-based recommendations Medikamentöse Therapie der Endometriose: Aktuelle Therapieempfehlungen auf Basis der S2k-Leitlinie. Die Gynäkologie. https://doi.org/10.1007/s00129-026-05522-7

MLA:

Burghaus, Stefanie. "Medical treatment of endometriosis: Current evidence and guideline-based recommendations Medikamentöse Therapie der Endometriose: Aktuelle Therapieempfehlungen auf Basis der S2k-Leitlinie." Die Gynäkologie (2026).

BibTeX: Download